Kristen Scholz

Kristen Scholz has a diverse work experience in the pharmaceutical and healthcare industry. Kristen is currently working as the Vice President of Medical Affairs at UroGen Pharma. Prior to this, they held a similar role at FerGene, where they also served as the Senior Director of Medical Affairs.

Before joining FerGene, Kristen worked at Pfizer as a Senior Medical Director at Meridian Medical Technologies and also served as a Field Medical Director. Kristen then transitioned to Photocure ASA as the Senior Director of US Medical Affairs.

In their earlier roles, Kristen held positions at AbbVie as the Therapeutic Area Lead in Oncology Hematology, Shire as the Head of US Medical Affairs in Oncology, and Ipsen as the Director of Oncology/Endocrinology Medical Science Liaisons. Kristen also worked at Endocyte as the Lead Associate Scientific Director, where they created and led a field-based team of scientific experts focused on providing scientific education and ensuring study enrollment objectives in oncology trials.

Kristen began their career at GE Healthcare as an Assistant Medical Director. With over a decade of experience, Kristen Scholz has proven expertise in medical affairs, clinical trials, and oncology.

Kristen Scholz has a Doctor of Health Science (DHSc) degree from Nova Southeastern University. Kristen also holds an MBA in Business Administration from the University of Massachusetts Amherst. Kristen has a Master of Science in Nursing Administration (MSN) from the Medical University of South Carolina. Additionally, they have a Bachelor of Science in Nursing (BSN) and an Associate of Science in Nursing (ASN) from Xavier University. In 2020, Kristen completed a certification in Medical Affairs in Medicines Development from King's College London.